Table 4.

Postpartum data.

Breastfeeding, n (%)
0–3 months	6 (54.5)
>3 months	2 (18.2)
No breastfeeding	3 (27.3)
Treatment within 12 months after delivery, n (%)
Natalizumab	8 (72.8)
Fingolimod	2 (18.2)
No drug	1 (9.1)
Restart of medication after delivery (days)
Mean ± SD	132 ± 101
Range (min–max)	7–278
EDSS at delivery
Mean ± SD	2 ± 1.4
Range (min–max)	0–4.5
EDSS 12 months postpartum
Mean ± SD	1.8 ± 1.4
Range (min–max)	0–4
EDSS change*
Mean ± SD	0.5 ± 1.3
Range (min–max)	−0.5–4
Relapse within 12 months after delivery, n (%)
No relapse	8 (72.7)
1 relapse	2 (18.2)
2 relapses	1 (9.1)
>2 relapses	0 (0)

EDSS, Expanded Disability Status Scale; max, maximum; min, minimum; n, number; SD, standard deviation;%, percentage.

^*EDSS at pregnancy onset compared to 12 months postpartum.